Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bifeprunox

Known as: 1-(2-Oxo-benzoxazolin-7-yl)-4-(3-biphenyl)methylpiperazinemesylate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Aripiprazole is the first dopamine D(2)/D(3) receptor partial agonist successfully developed and ultimately approved for… Expand
Is this relevant?
Review
2010
Review
2010
Serotonin 5-HT1A receptors are attractive targets for the development of improved antipsychotics. Indeed, extensive evidence in… Expand
Is this relevant?
2009
2009
Abstract The atypical antipsychotic bifeprunox is a partial dopamine D2 and 5-HT1A receptor agonist. Using in-vivo… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Several novel antipsychotics activate serotonin 5-HT1A receptors as well as antagonising dopamine D2/3 receptors. Such a… Expand
Is this relevant?
2008
2008
Because long-term antipsychotics elicit behavioral dopamine supersensitivity, the present study examined whether 7-9 days… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
RationaleBifeprunox is a partial dopamine agonist with a unique receptor-binding profile and potential antipsychotic properties… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2007
2007
Aripiprazole is the first dopamine D(2) receptor partial agonist approved for use in schizophrenia and bipolar disorder. Other… Expand
Is this relevant?
2006
2006
Dopamine D2 receptor antagonists induce hyperprolactinemia depending on the extent of D2 receptor blockade. We compared the… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Several novel antipsychotics, such as aripiprazole, bifeprunox, SSR181507 [(3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Considerable interest has arisen in identifying antipsychotic agents with improved efficacy against negative symptoms, such as… Expand
Is this relevant?